These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2427571)

  • 1. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
    Golden HW; Crean GL; Iacuzio DA; Otterness IG
    J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.
    Golden HW; Iacuzio DA; Otterness IG
    Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of ticks from guinea pigs by anti-hapten-antibody-mediated degranulation of basophils at cutaneous basophil hypersensitivity sites: role of mediators other than histamine.
    Brown SJ; Askenase PW
    J Immunol; 1985 Feb; 134(2):1160-5. PubMed ID: 2578152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG1 antibody-dependent mediator release after passive systemic sensitization of basophils arriving at cutaneous basophil hypersensitivity reactions.
    Mitchell EB; Brown SJ; Askenase PW
    J Immunol; 1982 Oct; 129(4):1663-9. PubMed ID: 6180018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous basophil anaphylaxis. Immediate vasopermeability increases and anaphylactic degranulation of basophils at delayed hypersensitivity reactions challenged with additional antigen.
    Askenase PW; Debernardo R; Tauben D; Kashgarian M
    Immunology; 1978 Nov; 35(5):741-55. PubMed ID: 721140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic degranulation of guinea pig basophilic leukocytes. I. Fusion of granule membranes and cytoplasmic vesicles formation and resolution of degranulation sacs.
    Dvorak AM; Galli SJ; Morgan E; Galli AS; Hammond ME; Dvorak HF
    Lab Invest; 1981 Feb; 44(2):174-91. PubMed ID: 6162057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
    Mackay GA; Pearce FL
    Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of basophils and mast cells in cutaneous basophil hypersensitivity reaction.
    Kishimoto T; Soda R; Takahashi K; Kimura I
    Clin Exp Immunol; 1987 Mar; 67(3):611-6. PubMed ID: 3608232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent.
    Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D
    J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A binding site on mast cells and basophils for the anti-allergic drug cromolyn.
    Mazurek N; Berger G; Pecht I
    Nature; 1980 Aug; 286(5774):722-3. PubMed ID: 6157990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged reduction in basophil counts at cutaneous basophil hypersensitivity reaction sites challenged with antigen.
    Desaules M; Askenase PW
    Immunology; 1982 Jun; 46(2):381-5. PubMed ID: 7084994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A; Coutts SM; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between cutaneous basophil hypersensitivity and basophil sensitization.
    Lett-Brown MA; Thueson DO; Grant JA
    J Immunol; 1982 Sep; 129(3):1262-6. PubMed ID: 7108205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.